ClassID:

94073

C07D207/333 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms Radicals substituted by oxygen or sulfur atoms

Recent Application in this class:
#1
20250345777
2025-11-13

BISMUTHENE AS VERSATILE PHOTOCATALYST OPERATING UNDER VARIABLE CONDITIONS FOR PHOTOREDOX C-H BOND FUNCTIONALIZATION

#2
20250326716
2025-10-23

PROCESS AND SYSTEM FOR CONTINUOUSLY PRODUCING 5-HYDROXYMETHYLFURFURAL AND 2,5-FURANDICARBOXYLIC ACID

#3
20250305953
2025-10-02

LIGHT-EMITTING RADICAL CATION PROBE IN SITU GENERATED BY ACID INDUCTION, AND PREPARATION THEREFOR AND APPLICATION THEREOF

#4
20250179243
2025-06-05

MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM

#5
20250042850
2025-02-06

PHARMACEUTICAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

#6
20240239745
2024-07-18

METHOD FOR SYNTHESIZING BILIRUBIN

#7
20240116894
2024-04-11

PROTEASOME ACTIVITY ENHANCING COMPOUNDS

#8
20230088365
2023-03-23

PROCESS FOR PRODUCING PYRROLE COMPOUND

#9
20230026724
2023-01-26

SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF

#10
20220324807
2022-10-13

Aromatic sulfonamide derivatives

#11
20220324806
2022-10-13

Cannabinoid derivatives

#12
20220169603
2022-06-02

NOVEL SALTS, CRYSTALLINE FORMS AND PREMIX OF HYPOLIPIDEMIC AGENT

#13
20210230131
2021-07-29

POLYAMINO BIARYL COMPOUNDS AND THEIR USE

#14
20210188802
2021-06-24

Proteasome activity enhancing compounds

#15
20210188763
2021-06-24

COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION

#16
20210070705
2021-03-11

Process for producing pyrrole compound

#17
20200384451
2020-12-10

PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF

#18
20200299270
2020-09-24

Proteostasis regulators

#19
20200223797
2020-07-16

Adducts formed from primary amines, dicarbonyl derivatives, inorganic oxide hydroxydes and sp-hybridized carbon allotropes

#20
20200182617
2020-06-11

Necrosis inhibitors

#21
20200157463
2020-05-21

Pyrrole compound, method of making same, and aroma composition, food, drink and cosmetics containing same

#22
20200115336
2020-04-16

Process for producing pyrrole compound

#23
20200010425
2020-01-09

Compounds useful as modulators of TRPM8

#24
20190389797
2019-12-26

PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES

#25
20190330147
2019-10-31

Pyrrolomycins and methods of using the same

#26
20190300479
2019-10-03

Method of treatment

#27
20190194386
2019-06-27

Conducting Polymers and Uses Thereof

#28
20190161479
2019-05-30

Compounds

#29
20190127324
2019-05-02

5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same

#30
20190119210
2019-04-25

Aromatic sulfonamide derivatives

#31
20190100492
2019-04-04

TREATMENT FOR LIPODYSTROPHY

#32
20190038578
2019-02-07

Necrosis inhibitors

#33
20190001316
2019-01-03

Markovnikov-selective palladium catalyst for carbonylation of alkynes with heteroarenes

#34
20180346426
2018-12-06

Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

#35
20180327375
2018-11-15

Aromatic surfactants

#36
20180312523
2018-11-01

Propionic acid derivatives and methods of use thereof

#37
20180305311
2018-10-25

Synergistic compositions

#38
20180297946
2018-10-18

POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF

#39
20180297945
2018-10-18

POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF

#40
20180265466
2018-09-20

Pyrrole compound, compositions and process for preparation thereof

#41
20180263960
2018-09-20

Modulators of CA release-activated CA (CRAC) channels and pharmaceutical uses thereof

#42
20180194725
2018-07-12

Pyrrolomycins and methods of using the same

#43
20180078526
2018-03-22

Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio

#44
20180009746
2018-01-11

5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same

#45
20170369447
2017-12-28

Compounds useful as modulators of TRPM8

#46
20170320878
2017-11-09

Method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous catalysis

#47
20170320823
2017-11-09

Synergistic compositions

#48
20170275169
2017-09-28

Adducts between carbon allotropes and serinol derivatives

#49
20170247355
2017-08-31

Proteostasis regulators

#50
20170158718
2017-06-08

Titanium (IV) compounds and methods of forming heterocyclic compounds using same

#51
20170144968
2017-05-25

Process for preparation of pyrroles having hypolipidemic hypocholesteremic activities

#52
20170121283
2017-05-04

Use of a novel 3-aryl-4-catechol-pyrrole-N-propanol compound and the derivatives thereof to treat cancer and diseases related to excessive angiogenesis

#53
20170101376
2017-04-13

Process for the synthesis of 2-(2,5-dimethyl-1H-pyrrol-1-yl)-1,3-propanediol and its substituted derivatives

#54
20170027926
2017-02-02

Compositions and methods of inhibiting histone deacetylases

#55
20170008820
2017-01-12

Method for producing optically active carboxylic acid ester

#56
20160376260
2016-12-29

Slow release of organoboronic acids in cross-coupling reactions

#57
20160280626
2016-09-29

Antidiabetic bicyclic compounds

#58
20160214989
2016-07-28

Compositions and methods for enhancing proteasome activity

#59
20160207884
2016-07-21

Polymorphic form of pyrrole derivative and intermediate thereof

#60
20160200746
2016-07-14

Titanium (IV) compounds and methods of forming heterocyclic compounds using same

#61
20160200678
2016-07-14

Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio

#62
20160194280
2016-07-07

Process for the preparation of saroglitazar pharmaceutical salts

#63
20160185730
2016-06-30

Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

#64
20160137600
2016-05-19

Pyrrole derivatives as alpha 7 nAChR modulators

#65
20160107990
2016-04-21

4-(5-(4-chlorophenyl)-2-(2-cyclopropylacetyl)-1,4-dimethyl-1H-pyrrol-3-yl)benzenesulfonamide as alpha 7 nAChR modulator

#66
20160083409
2016-03-24

METHOD FOR THE PREPARATION OF alpha-SUBSTITUTED ACRYL ALDEHYDES

#67
20160068484
2016-03-10

Synergistic compositions

#68
20160046642
2016-02-18

Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections

#69
20150376136
2015-12-31

Compounds useful as modulators of TRPM8

#70
20150361041
2015-12-17

Pyrrole derivatives as alpha 7 nAChR modulators

#71
20150344460
2015-12-03

N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer

#72
20150246905
2015-09-03

Slow release of organoboronic acids in cross-coupling reactions

#73
20150038717
2015-02-05

Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound

#74
20150038716
2015-02-05

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

#75
20150038712
2015-02-05

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

#76
20150038711
2015-02-05

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

#77
20150038710
2015-02-05

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

#78
20140323501
2014-10-30

AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

#79
20140303378
2014-10-09

Process for producing pyrrole compound

#80
20140296527
2014-10-02

Processes for the preparation of pyrrolidine intermediates

#81
20140275182
2014-09-18

Bicyclic pyrrole derivatives useful as agonists of GPR120

#82
20140275169
2014-09-18

Combination Therapies for Enhancing Protein Degradation

#83
20140113938
2014-04-24

Pyrrole inhibitors of S-nitrosoglutathione reductase

#84
20140051697
2014-02-20

Substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections

#85
20140018327
2014-01-16

Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease

#86
20130338209
2013-12-19

Treatment for lipodystrophy

#87
20130331387
2013-12-12

Heteroaryl derivatives as alpha7 nAChR modulators

#88
20130317223
2013-11-28

Slow release of organoboronic acids in cross-coupling reactions

#89
20130310419
2013-11-21

PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR

#90
20130165494
2013-06-27

1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors

#91
20130109721
2013-05-02

FAAH Inhibitors

#92
20130096105
2013-04-18

Arylsulfonamide based matrix metalloprotease inhibitors

#93
20130045992
2013-02-21

Compositions and Methods for Enhancing Proteasome Activity

#94
20120316193
2012-12-13

Proteostasis regulators

#95
20120308588
2012-12-06

Neprilysin inhibitors

#96
20120258954
2012-10-11

Arylsulfonamide based matrix metalloprotease inhibitors

#97
20120196915
2012-08-02

Antitumor 1,2-Diphenylpyrrole Compounds and their Preparation Process

#98
20120065064
2012-03-15

Herbicides

#99
20120022075
2012-01-26

Phenylpyrrole derivative

#100
20120015911
2012-01-19

Method and compositions for treating amyloid-related diseases

#101
20120010264
2012-01-12

NOVEL MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT

#102
20110306769
2011-12-15

Process for producing pyrrole compound

#103
20110293520
2011-12-01

NEW DRUG FOR INHIBITING AGGREGATION OF PROTEINS INVOLVED IN DISEASES LINKED TO PROTEIN AGGREGATION AND/OR NEURODEGENERATIVE DISEASES

#104
20110275669
2011-11-10

Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine

#105
20110207728
2011-08-25

Substituted imidazo[1,2-α]pyrrolo[1,2-]pyrazines for treating respiratory syncytial virus (RSV) infections

#106
20110160165
2011-06-30

7-pyrazolyl tetracycline compounds and methods of use thereof

#107
20110144170
2011-06-16

Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS

#108
20110136875
2011-06-09

Pyrrole inhibitors of S-nitrosoglutathione reductase

#109
20110118303
2011-05-19

Compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these

#110
20110039841
2011-02-17

Novel compounds, their preparation and use

#111
20110014186
2011-01-20

Arylsulfonamide-based matrix metalloprotease inhibitors

#112
20110003787
2011-01-06

Phenylpyrrole derivative

#113
20100240660
2010-09-23

Histone deacetylases inhibitors

#114
20100210524
2010-08-19

NOVEL ESTROGEN RECEPTOR LIGANDS

#115
20100130743
2010-05-27

HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES

#116
20100121062
2010-05-13

Slow release of organoboronic acids in cross-coupling reactions

#117
20100121055
2010-05-13

PROCESSES FOR PREPARING (R)-2-METHYLPYRROLIDINE AND (S)-2-METHYLPYRROLIDINE AND TARTRATE SALTS THEREOF

#118
20100081826
2010-04-01

Process for preparing five-membered heterocyclyl tetracycline compounds and methods of use thereof

#119
20100056522
2010-03-04

INTRAOCULAR PRESSURE-LOWERING AGENT COMPRISING COMPOUND HAVING HISTONE DEACETYLASE INHIBITOR EFFECT AS ACTIVE INGREDIENT

#120
20100048664
2010-02-25

Therapeutic substituted pyrroles

#121
20100028368
2010-02-04

Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof

#122
20100016383
2010-01-21

4-(3,3-DIHALO-ALLYLOXY)PHENOL DERIVATIVES HAVING PESTICIDAL PROPERTIES

#123
20090326018
2009-12-31

2-Phenyl indene derivatives useful as estrogen receptor ligands

#124
20090281358
2009-11-12

Heterogeneous chiral catalyst

#125
20090275575
2009-11-05

Benzophenone derivatives useful for inhibiting formation of microtubule

#126
20090264500
2009-10-22

3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors

#127
20090253659
2009-10-08

Cycloalkylidene compounds as modulators of estrogen receptor

#128
20090240058
2009-09-24

Activator for Peroxisome Proliferator-Activating Receptor Delta

#129
20090215958
2009-08-27

Conducting polymers and uses thereof

#130
20090209588
2009-08-20

Compounds, their preparation and use

#131
20090142618
2009-06-04

OLED device employing alkali metal cluster compounds

#132
20090130769
2009-05-21

Novel Cross-Linkers For Obtaining Structure Information On Molecule Complexes

#133
20090118169
2009-05-07

NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF

#134
20090099139
2009-04-16

NITROSATED AND NITROSYLATED CYCLOOXYGENASE-2 INHIBITORS, COMPOSITIONS AND METHODS OF USE

#135
20090062284
2009-03-05

Thio-substituted biarylmethanesulfinyl derivatives

#136
20090054379
2009-02-26

7-pyrollyl 9-aminoacyl tetracycline compounds and methods of use thereof

#137
20090018167
2009-01-15

Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states

#138
20080306275
2008-12-11

NOVEL HETEROARYL DERIVATIVE

#139
20080287424
2008-11-20

AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORS

#140
20080275103
2008-11-06

Anti-tubulin acting arylpyrrol, arylfuran and arylthiophene derivatives, method for the preparation thereof and for the use thereof as an antimitotic

#141
20080194839
2008-08-14

Synthesis of porphyrins designed for attachment to electroactive surfaces via one or more carbon tethers

#142
20080188402
2008-08-07

Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine

#143
20080146632
2008-06-19

Fc receptor modulating compounds and compositions

#144
20080096892
2008-04-24

C-kit modulators and methods of use

#145
20080096889
2008-04-24

Histone deacetylases inhibitors

#146
20080033013
2008-02-07

Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation

#147
20080027232
2008-01-31

Boron complexation strategy for use in manipulating 1-acyldipyrromethanes

#148
20070299085
2007-12-27

Heterocycle-substituted n-phenyl-phthalamide derivatives, related compounds and their use as insecticides

#149
20070275956
2007-11-29

Novel Heterocyclic Compounds

#150
20070238776
2007-10-11

Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine

#151
20070213348
2007-09-13

Cycloalkylidene compounds as modulators of estrogen receptor

#152
20070155839
2007-07-05

Cycloalkylidene compounds as modulators of estrogen receptor

#153
20070134729
2007-06-14

Novel antibacterial agents

#154
20070123495
2007-05-31

PYRROLO-NAPHTHYL ACIDS AND METHODS FOR USING THEM

#155
20070088158
2007-04-19

Boron complexation strategy for use in manipulating 1-acyldipyrromethanes

#156
20070082912
2007-04-12

Pyrrole compounds for the treatment of prostaglandine mediated diseases

#157
20070072906
2007-03-29

Pyrrole compounds

#158
20070060571
2007-03-15

Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use

#159
20070054884
2007-03-08

4-SUBSTITUTED 2-ARYLOXYPHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS

#160
20060280746
2006-12-14

Alpha, beta-unsaturated sulfoxides for treating proliferative disorders

#161
20060270718
2006-11-30

Heterocyclic arylsulfonamidobenzylic compounds

#162
20060264484
2006-11-23

Fc receptor modulating compounds and compositions

#163
20060258730
2006-11-16

Sulfonic acids, their derivatives and pharmaceutical compositions containing them

#164
20060241259
2006-10-26

Oxime ester photoinitiators with heteroaromatic groups

#165
20060223855
2006-10-05

Methods and compositions for treating amyloid-related diseases

#166
20060194857
2006-08-31

Heteroaryl derivative

#167
20060189549
2006-08-24

Chalcone derivatives and their use to treat diseases

#168
20060183790
2006-08-17

Azolylacylguanidines as β-secretase inhibitors

#169
20060122239
2006-06-08

Arylsulfonamidobenzylic compounds

#170
20060084634
2006-04-20

Five-membered heterocyclyl tetracycline compounds and methods of use thereof

#171
20060052436
2006-03-09

Pyrroloterpenes and use of the same as antimicrobial and anticancer agents

#172
20060052349
2006-03-09

Pyrrolo-naphthyl acids and methods for using them

#173
20060009638
2006-01-12

Synthesis of porphyrins designed for attachment to electroactive surfaces via one or more carbon tethers

#174
20060004063
2006-01-05

Inhibitors of HCV NS5B polymerase

#175
20050288186
2005-12-29

4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties

#176
20050282778
2005-12-22

Boron complexation strategy for use in manipulating 1-acyldipyrromethanes

#177
20050245747
2005-11-03

Thio-substituted biaryl-methanesulfinyl derivatives

#178
20050240028
2005-10-27

Pyrrolyl complexes of copper for copper metal deposition

#179
20050234059
2005-10-20

Heterocyclic inhibitors of ERK2 and uses thereof

#180
20050227978
2005-10-13

Fibrosis inhibitor

#181
20050148599
2005-07-07

Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states

#182
20050101657
2005-05-12

Androgen receptor antagonists

#183
20050101651
2005-05-12

Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis

#184
20050080058
2005-04-14

Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments

#185
19187833
2025-09-09

Green synthesis method for forming substituted pyrroles

#186
14200114
2014-12-16

Bicyclic pyrrole derivatives useful as agonists of GPR120